Replies to post #689415 on NorthWest Biotherapeutics Inc (NWBO)

[Nemesis18]

DCVAX-L has not met the high bar required by the MHRA for a new cancer vaccine.
It was allowed to have a regulatory shot at Marketing Approval, mostly because of political pressure, but it has fallen short, in my opinion.

Further, I believe that NWBO Already know this to be the case, hence the protracted silence,